Fresh analysis indicates that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who stop conventional lifestyle regimens.
Research printed in a leading health publication demonstrates that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users buying such drugs should be informed of the danger of rapid weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.
Such speed of regain implies a reversion to starting weight within about 18 months.
Weighing Approaches
The analysis, which examined 37 of studies involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.
Researchers note that people who shed pounds through lifestyle changes alone typically have a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Experts propose the way of the injections accounts for the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."
A Chronic Condition?
Health authorities suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, due to the high risk of weight regain, the treatment might need to be long-term.
This opinion is reinforced by drug manufacturers, who state that the results "highlight the long-term character of obesity," akin to managing diseases like high blood pressure.
User Accounts
Users who have discontinued the medication explain a powerful return of cravings.
"It was like a switch activating and I was suddenly extremely hungry," recalled a patient.
The struggle is compounded if individuals have not adopted lasting dietary or behavioural changes during therapy.
Widespread Adoption
Figures show that millions of adults in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is more common among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while the jabs are effective agents for weight loss, they are not a permanent cure and long-term success hinges on integrated lifestyle changes.
